Dr. De La Zerda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1295 NW 14th St
Miami, FL 33125Phone+1 305-243-4000
Education & Training
- University of California (San Diego) Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2014
- University of California (San Francisco)/FresnoResidency, Internal Medicine, 2007 - 2010
- Pontifical Xavierian UniversityClass of 2003
Certifications & Licensure
- CA State Medical License 2009 - 2025
- FL State Medical License 2014 - 2025
- PA State Medical License 2021 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 614 citationsTocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.Ivan O. Rosas, Norbert Bräu, Michael F. Waters, Ronaldo C. Go, Bradley D Hunter
The New England Journal of Medicine. 2021-02-25 - 21 citationsEffects of Tocilizumab in COVID-19 patients: a cohort study.Christine A. Vu, Kailynn DeRonde, Ana D Vega, Meshell Maxam, Gregory E. Holt
BMC Infectious Diseases. 2020-12-22 - 61 citationsInhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE studySteven D. Nathan, Aaron B. Waxman, Sudarshan Rajagopal, Amy Case, Shilpa Johri
The Lancet. Respiratory Medicine. 2021-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: